Clinical Trial Update: A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI). [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Minirin Melt (desmopressin) in Japanese patients with Central Diabetes Insipidus is reported. The study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Diabetes Insipidus

Drugs mentioned

• Minirin Melt (desmopressin)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Central Diabetes Insipidus | Phase 3 | Status: COMPLETED